LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

Home・Aandelen Lijst・Intuitive Surgical Inc

Intuitive Surgical Inc

Gesloten

SectorGezondheidszorg

424.07 0.17

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

419.65

Max

425.8

Belangrijke statistieken
By Trading Economics
Inkomsten	22M 822M
Verkoop	-95M 2.8B
K/W Sectorgemiddelde	53.168 50.102
EPS	2.5
Winstmarge	29.648
Werknemers	17,021
EBITDA	-230M 855M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+34.46% upside

Dividenden
By Dow Jones
Volgende Winsten	21 jul 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-10B 155B
Vorige openingsprijs	423.9
Vorige sluitingsprijs	424.07

Nieuwssentiment

By Acuity

39%

61%

112 / 344 Rangschikking in Healthcare

Intuitive Surgical Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

22 apr 2026, 15:47 UTC

Belangrijke Marktbewegers

Intuitive Surgical Shares Rise After 1Q Beat

21 apr 2026, 20:54 UTC

Winsten

Intuitive Surgical Posts Higher 1Q Sales, Profit

22 apr 2026, 11:27 UTC

Winsten

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

21 apr 2026, 21:14 UTC

Winsten

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

21 apr 2026, 20:38 UTC

Winsten

Intuitive Surgical 1Q Rev $2.77B >ISRG

21 apr 2026, 20:38 UTC

Winsten

Intuitive Surgical 1Q Net $821.5M >ISRG

21 apr 2026, 20:38 UTC

Winsten

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 431.00 >ISRG

21 apr 2026, 20:38 UTC

Winsten

Intuitive Surgical 1Q Adj EPS $2.50 >ISRG

21 apr 2026, 20:38 UTC

Winsten

Intuitive Surgical 1Q EPS $2.28 >ISRG

21 apr 2026, 20:14 UTC

Winsten

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of About 13.5% to 15.5%

21 apr 2026, 20:14 UTC

Winsten

Intuitive Surgical 1Q Rev $2.77B

21 apr 2026, 20:13 UTC

Winsten

Intuitive Surgical 1Q Adj EPS $2.50

21 apr 2026, 20:12 UTC

Winsten

Intuitive Surgical 1Q EPS $2.28

14 apr 2026, 14:13 UTC

Winsten

Johnson & Johnson Financial Chief Sees 'Clear Line of Sight' to Double-Digit Growth by 2030 -- Barrons.com

14 apr 2026, 12:57 UTC

Winsten

Johnson & Johnson Financial Chief Sees 'Clear Line of Sight' to Double-Digit Growth by 2030 -- Barrons.com

17 feb 2026, 14:48 UTC

Winsten

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

23 jan 2026, 16:07 UTC

Winsten

Intuitive Surgical Stock Beats Earnings Estimates. The Stock Is Barely Moving. -- Barrons.com

23 jan 2026, 12:58 UTC

Winsten

Intuitive Surgical Stock Rises on Earnings. What Wall Street Is Saying. -- Barrons.com

22 jan 2026, 21:11 UTC

Winsten

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

22 jan 2026, 21:11 UTC

Winsten

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

22 jan 2026, 21:10 UTC

Winsten

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

22 jan 2026, 21:05 UTC

Winsten

Intuitive Surgical 4Q EPS $2.21 >ISRG

22 jan 2026, 21:05 UTC

Winsten

Intuitive Surgical 4Q Rev $2.87B >ISRG

22 jan 2026, 21:05 UTC

Winsten

Intuitive Surgical 4Q Net $794.8M >ISRG

22 jan 2026, 21:05 UTC

Winsten

Intuitive Surgical 4Q Adj EPS $2.53 >ISRG

22 jan 2026, 21:05 UTC

Winsten

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 532.00 >ISRG

30 okt 2025, 12:38 UTC

Winsten

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

30 okt 2025, 12:01 UTC

Winsten

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

22 okt 2025, 15:42 UTC

Winsten

Intuitive Surgical Stock Jumps on Earnings. Its Newest Surgical Robot Is Going Gangbusters. -- Barrons.com

22 okt 2025, 12:34 UTC

Winsten

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

Peer Vergelijking

Prijswijziging

Intuitive Surgical Inc Prognose

Koersdoel

By TipRanks

34.46% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 569.61 USD 34.46%

Hoogste 670 USD

Laagste 451 USD

Gebaseerd op 20 Wall Street-analisten die 12-maands prijsdoelen bieden voor Intuitive Surgical Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

20 ratings

Buy

Hold

Sell

Gebaseerd op 20 analisten die aandelenratings hebben gegeven aan Intuitive Surgical Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

112 / 344 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.